[Evolution of the regulatory framework in clinical research]

Bull Cancer. 2019 Apr;106(4):389-394. doi: 10.1016/j.bulcan.2019.01.016. Epub 2019 Mar 15.
[Article in French]

Abstract

The regulatory framework of clinical research is necessary to ensure the protection of participants and to define the actors and their responsibilities. Although main principles have been set up in 1947 with the Nuremberg Code, this regulatory framework is relatively recent in Europe: development of national regulations in the years 1980-1990, first European Directive regarding clinical trials in 2001. In France, as 2006 was marked by the implementation of this first "Clinical trials Directive", the end of the year 2016 and the following months were marked by the enforcement of the Jardé law (previously modified in order to reinforce the regulatory requirements following the death of an healthy volunteer in a clinical trial). As clinical researches involve processing of personal data, the entry into force, on 25 May 2018, of the General Data Protection Regulation (GDPR) had also consequences on their implementation. Finally, regarding clinical trials on drugs, the "Clinical trials Regulation" repealing the Directive, voted in 2014, should come into force in the coming months.

Keywords: Clinical Trials Regulation; General Regulation on Data Protection; Jardé Law; Loi Jardé; Recherches impliquant la personne humaine; Researches involving human beings; Règlement essais cliniques; Règlement général sur la protection des données.

Publication types

  • Review

MeSH terms

  • Biomedical Research / ethics
  • Biomedical Research / legislation & jurisprudence*
  • Clinical Trials as Topic / ethics
  • Clinical Trials as Topic / legislation & jurisprudence*
  • Confidentiality / ethics
  • Confidentiality / legislation & jurisprudence*
  • Europe
  • France
  • Humans
  • Research Subjects / legislation & jurisprudence*